跳转至内容
Merck
CN
  • Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation.

Lipolysis-derived linoleic acid drives beige fat progenitor cell proliferation.

Developmental cell (2022-12-07)
Ichitaro Abe, Yasuo Oguri, Anthony R P Verkerke, Lauar B Monteiro, Carly M Knuth, Christopher Auger, Yunping Qiu, Gregory P Westcott, Saverio Cinti, Kosaku Shinoda, Marc G Jeschke, Shingo Kajimura
摘要

De novo beige adipocyte biogenesis involves the proliferation of progenitor cells in white adipose tissue (WAT); however, what regulates this process remains unclear. Here, we report that in mouse models but also in human tissues, WAT lipolysis-derived linoleic acid triggers beige progenitor cell proliferation following cold acclimation, β3-adrenoceptor activation, and burn injury. A subset of adipocyte progenitors, as marked by cell surface markers PDGFRα or Sca1 and CD81, harbored cristae-rich mitochondria and actively imported linoleic acid via a fatty acid transporter CD36. Linoleic acid not only was oxidized as fuel in the mitochondria but also was utilized for the synthesis of arachidonic acid-derived signaling entities such as prostaglandin D2. Oral supplementation of linoleic acid was sufficient to stimulate beige progenitor cell proliferation, even under thermoneutral conditions, in a CD36-dependent manner. Together, this study provides mechanistic insights into how diverse pathophysiological stimuli, such as cold and burn injury, promote de novo beige fat biogenesis.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
泰莫西芬, ≥99%
Sigma-Aldrich
3-异丁基-1-甲基黄嘌呤, ≥99% (HPLC), powder
Sigma-Aldrich
白蛋白 溶液 来源于牛血清, 10% in DPBS, low endotoxin, fatty acid free, suitable for cell culture, sterile-filtered
Sigma-Aldrich
羰基氰化物 4-(三氟甲氧基)苯腙, ≥98% (TLC), powder
Roche
分散酶®II (中性蛋白酶, II级), lyophilized, from bacterial, Roche, pkg of 5 × 1 g
Sigma-Aldrich
抗-β-肌动蛋白−过氧化物酶抗体,小鼠单克隆 小鼠抗, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Baicalein, A cell-permeable flavone that inhibits the activity of 12-lipoxygenase (IC₅₀= 120 nM) and reverse transcriptase.
Sigma-Aldrich
MK-886, A cell-permeable, orally active NSAID that blocks cellular Cox pathway PGE2 production by inhibiting COX-1 and mPGES-1, but not COX-2, activity, as well as suppresses cellular 5-LO pathway activation by inhibiting FLAP, rather than 5-LO, activity.
Sigma-Aldrich
SC-560, A cell-permeable, highly potent and selective inhibitor of COX-1 (IC₅₀ = 9 nM).